However, avoiding antithrombotics is becoming increasingly diffi cult because of expanding indications for their use and an ageing population. 4 In this cohort study, systematic review, and metaanalysis, the authors used data from the Scottish Audit of Intracranial Vascular Malformations and the published literature to establish whether antithrombotic use was associated with new focal neurological deficits or bleeding.
1 Patients were identified by screening of all radiology reports within a defined geographical area (Scotland, UK) for diagnosed CCMs. Active surveillance was then used to identify patients who had either new episodes of documented bleeding or new focal neurological deficits in the absence of new bleeding, as well as treatment with antithrombotics.
Despite the widely held clinical concern that antithrombotic drugs could increase the risk of bleeding, the findings from the study suggested the opposite. There were fewer episodes of new bleeding or new focal neurological deficits over a mean follow-up of 11·6 years in the patients given antithrombotics (one [2%] of 61 patients) than in those who did not take antithrombotics (29 [12%] of 239).
The adjusted hazard ratio (HR) of 0·12 (95% CI 0·02-0·88) was remarkably low, given that HRs that small are rarely seen in clinical research. In secondary prevention trials, for example, aspirin prevents recurrent stroke with an HR of 0·83. 5 Therefore, potential sources of bias should be considered. The most plausible source of bias could be confounding by indication. That is, if clinicians mostly use antithrombotics in patients at lower risk for haemorrhage, but not in patients at higher risk, then a spurious association might be detected between antithrombotic use and lower recurrence of haemorrhages. To mitigate this risk for bias, the authors adjusted for type of presentation and brainstem location, 3 the two factors that influence bleeding risk that would also be known to the treating clinician and might have influenced their treatment decisions. There was no change in the HR after adjustment.
A series of subgroup and sensitivity analyses provide additional reassurance that the findings are consistent with the conclusion that antithrombotics might be protective in these patients. In each analysis, the estimates were in the same direction, with a clinically relevant effect, although not statistically significant, possibly because of the small sizes of the groups or the small number of events. These analyses included patients taking anticoagulants (none of 10 patients), individuals with intracerebral haemorrhage at presentation (adjusted HR 0·41, in 52 patients), and when antithrombotic therapy was analysed as a time-dependent covariate (adjusted HR 0·30). Importantly, when the outcome was restricted to intracerebral haemorrhage only, the direction of effect was similar but not significant (one [2%] of 62 patients vs 18 [8%] of 238; log-rank p=0·070). Furthermore, a systematic review of six other published and unpublished studies showed similar findings, with fewer intracerebral haemorrhages in the patients on antithrombotics.
1 Are these findings plausible on the basis of current knowledge of the pathophysiology of CCMs? Histologically, these lesions consist of dilated thin-walled vascular channels lined by endo thelium, with no or minimal intervening brain tissue, surrounded by gliosis and haemosiderin. 6 Thrombi within these channels are seen in about a half to three-quarters of cases. 7, 8 It is plausible that thrombosis could impair venous drain age or trigger inflam mation, with expression of metalloproteinases, lead ing to increased pressure and breakdown of the extracellular matrix, with consequent bleeding.
The findings from this study provide some reassurance that clinicians can use antithrombotics safely, if clearly indicated, in patients with CCMs-particularly when the patient is asymptomatic and excis ion or radiosurgery is not indicated or not possible. 9 Perhaps antithrombotics could even be used as a treat ment for CCMs, although it would be presumptuous to do so based only on
